Abstract

A simple capillary zone electrophoresis (CZE) method was used to characterize human very low-density lipoprotein (VLDL) particles for four healthy donors. One major peak was observed for native, in vitro oxidized and glycated VLDL particles. The effective mobilities and peak areas of the capillary electrophoresis (CE) profiles showed good reproducibility and precision. The mobility of the oxidized VLDL peak was higher than that of the native VLDL. The mobility of the glycated VLDL peak was similar to that of the native VLDL. Phospholipids isolated from VLDL particles were analyzed by our recently developed micellar electrokinetic chromatography (MEKC) with a high-salt stacking method. At absorbance 200 nm, the native VLDL phospholipids showed a major peak and a minor peak for each donor. For oxidized VLDL phospholipids, the area of the major peak reduced for three donors, possibly due to phospholipid decomposition. For glycated VLDL phospholipids, the peak mobilities were more positive than native VLDL phospholipids for two donors, possibly due to phospholipid-linked advanced glycation end products (AGEs). Very interestingly, at absorbance 234 nm, the major peak of oxidized VLDL phospholipids was resolved as two peaks for each donor, possibly due to conjugated dienes formed upon oxidation.

Highlights

  • Hepatocytes synthesize very low-density lipoprotein (VLDL) particles

  • Most of the hydrolyzed VLDL particles are re-uptaken by hepatocytes through the apo B/E receptor, and about 10%–20% of the hydrolyzed VLDL particles are further metabolized into low-density lipoprotein (LDL) particles [1]

  • The capillary electrophoresis (CE) profiles of the three VLDL particles showed a major peak with good precisions of effective mobility and peak area

Read more

Summary

Introduction

Hepatocytes synthesize very low-density lipoprotein (VLDL) particles. VLDL particles are large and heterogeneous (diameter: 30–80 nm; density: 0.95–1.006 g/mL). VLDL particle contains an apo B-100 protein and is enriched in triglyceride. VLDL particles are released into the plasma and are partially hydrolyzed by lipoprotein lipase (LPL) in the periphery. Most of the hydrolyzed VLDL particles are re-uptaken by hepatocytes through the apo B/E receptor, and about 10%–20% of the hydrolyzed VLDL particles are further metabolized into low-density lipoprotein (LDL) particles [1]. The characteristics of MS and T2D is dyslipidemia, which shows high levels of VLDL triglyceride, low levels of high-density lipoprotein (HDL) and increased numbers of small, dense LDL particles [3,4,5]. How the modified VLDL particles influence their further hydrolysis into

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call